Curiteva’s Inspire spine implants have been used in more than 10,000 levels, the medtech company said Jan. 21.
The interbody implants were launched in April 2023 and include cervical, posterior and anterior lumbar devices, according to a news release. A total 5,000 interbodies have been implanted in recent months.
“With an impressive 60% growth in surgeries and a 90% increase in our surgeon customer base over the past year, Inspires momentum shows no signs of slowing down,” David Schmidt, Curiteva’s CEO, said in the release. “2026 is poised to be a breakout year for Inspire and Curiteva.”
Curiteva plans to expand its Inspire line with standalone cervical and lateral systems prioritized for development.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
